Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-029794
Filing Date
2026-03-18
Accepted
2026-03-18 08:08:53
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2307
2 POWER OF ATTORNEY ea028181102ex24.htm EX-24 7139
  Complete submission text file 0001213900-26-029794.txt   11147
Mailing Address NO. 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING CHINA China 100085
Business Address NO. 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING CHINA China 100085 86-10-82799800
SINOVAC BIOTECH LTD (Issuer) CIK: 0001084201 (see all company filings)

EIN.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address LATHAM& WATKINS 200 CLARENDON STREET BOSTON MA 02116
Business Address
WEIDONG YIN (Reporting) CIK: 0001264738 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32371 | Film No.: 26765525